A low molecular weight compound, which inhibits the GI-S transition in rat hepatocytes, was obtained by tryptic hydrolysis of human a2-macroglobulin followed by ultrafiltration at pH 10. It was purified by high-performance liquid chromatography on MBondapak CI8 and pBondapak NH2 with a practically q
Purification and partial characterization of a malignancy-associated glycoprotein
β Scribed by Wendy C. Taddei-Peters; Veer P. Bhavanandan; Eugene A. Davidson
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 750 KB
- Volume
- 182
- Category
- Article
- ISSN
- 0008-6215
No coin nor oath required. For personal study only.
β¦ Synopsis
The isolation from cancer patient serum of a glycoprotein (Cc) associated with the presence of a variety of malignancies was previously reported . Although preliminary chemical and physical data indicated that Cc was different from identified circulating glycoproteins, subsequent immunological studies suggested that it was closely related to a,-acid glycoprotein . Further analysis revealed the presence of two components in some Cc preparations and prompted a re-examination of the isolation and characterization data . In the present study, Cc was purified by a modified protocol which involved the use of pleural fluid obtained from individuals with cancer, and an a l-acid glycoprotein antibody column to remove contaminating al -acid glycoprotein . Typically, the material not retained by the antibody column gave a single band with M r 53 000 when subjected to sodium dodecyl sulfate-polyacrylamide electrophoresis . Amino terminal analysis revealed that the protein contained a blocked amino terminus, and carbohydrate analysis indicated that complex, asparagine-linked saccharide units were present . The product could be distinguished from a t-acid glycoprotein and other previously described circulating glycoproteins by several criteria, including molecular weight, isoelectric point, and amino acid and carbohydrate composition . One of three preparations isolated had an apparent M,, of 59 000 . Carbohydrate analysis as well as deglycosylation studies showed that the change in molecular weight was due to increased glycosylation .
π SIMILAR VOLUMES
A novel human glioma-associated extracellular matrix (ECM) glycoprotein has been identified by murine monoclonal antibody 81C6. The glycoprotein, designated GMEM, is expressed in the ECM of glioma and mesenchymal cell cultures, in the perivascular matrix of endothelial proliferations of human glioma